T-lymphocyte subsets in human lymph nodes: relative increase of OKT-8+ cells in neoplastic and reactive B-cell proliferation
- PMID: 6607799
- DOI: 10.1016/0090-1229(84)90020-5
T-lymphocyte subsets in human lymph nodes: relative increase of OKT-8+ cells in neoplastic and reactive B-cell proliferation
Abstract
Cell suspensions obtained from 54 human lymph nodes involved by different pathological conditions were characterized by conventional markers and by the OKT-3, OKT-4, OKT-8, OKIa-1, and OKM-1 monoclonal antibodies. In 18 cases of reactive lymphoid hyperplasia, the majority of lymph node cells were mature T lymphocytes (E-RFC = 56 +/- 9%; OKT-3+ = 63 +/- 10%); among T-cell subsets, OKT-4+ cells were 49 +/- 8% whereas OKT-8+ cells were 21 +/- 8% (T4/T8 = 2.7 +/- 1.1). This distribution of T-cell phenotypes was not similar in the different histological types of reactive lymphoid hyperplasia. In fact, an increase in the percentage of OKT-8+ cells (25 +/- 9%; P less than 0.05) and a decrease in the values of the T4/T8 ratio (2.1 +/- 1.0; P less than 0.05) were observed in 9 cases of reactive lymphoid hyperplasia of follicular type when they were compared to the mixed and sinus types. In 13 lymph nodes involved by B-cell lymphoma, the percentage of T lymphocytes was markedly reduced (E-RFC = 21 +/- 12%; OKT-3+ = 27 +/- 18%) and the percentage of OKIa-1+ cells (51 +/- 15%) was significantly (P less than 0.01) increased as compared to reactive nodes; in addition, in these cell suspensions, an increase in the relative proportion of OKT-8+ cells (T4/T8 = 1.4 +/- 0.7; P less than 0.01) could also be demonstrated. Finally, a clear prevalence of OKT-4+ cells on OKT-8+ cells was demonstrated in 5 cases of tuberculous lymphadenitis (T4/T8 = 3.9 +/- 1.5; NS) and in 18 cases of Hodgkin's disease (T4/T8 = 4.2 +/- 2.0; P less than 0.01). In tuberculous lymphadenitis, a significant increase (P less than 0.01) in the percentage of OKM-1+ cells could also be demonstrated.
Similar articles
-
T-lymphocyte subpopulations in B-cell-derived non-Hodgkin's lymphomas and Hodgkin's disease.Cancer. 1984 Aug 15;54(4):644-51. doi: 10.1002/1097-0142(1984)54:4<644::aid-cncr2820540410>3.0.co;2-a. Cancer. 1984. PMID: 6234982
-
Distribution of T-cell subsets identified by monoclonal antibodies in cell suspensions from lymph node biopsies of human B-cell lymphomas.Scand J Haematol. 1982 Apr;28(4):293-305. doi: 10.1111/j.1600-0609.1982.tb00530.x. Scand J Haematol. 1982. PMID: 6981200
-
Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodies.Leuk Res. 1983;7(4):523-37. doi: 10.1016/0145-2126(83)90047-4. Leuk Res. 1983. PMID: 6604849
-
Hodgkin's disease and anergy.Blut. 1979 Jan 22;38(1):1-7. doi: 10.1007/BF01082922. Blut. 1979. PMID: 365274 Review.
-
[Cellular populations of the lymph node. Immunohistochemical identification, morphology, histophysiology].Rev Med Interne. 1985 Mar;6(2):142-54. doi: 10.1016/s0248-8663(85)80058-8. Rev Med Interne. 1985. PMID: 3890051 Review. French. No abstract available.
Cited by
-
Immunologic complications of long-term implantation of a total artificial heart.J Clin Immunol. 1988 Jul;8(4):307-18. doi: 10.1007/BF00916559. J Clin Immunol. 1988. PMID: 3261735
-
Distribution of lymphocyte subsets and natural killer cells in the human body.Clin Investig. 1992 Jul;70(7):539-44. doi: 10.1007/BF00184787. Clin Investig. 1992. PMID: 1392422 Review.
-
Cell-mediated cytotoxic activity of regional lymph node cells from patients with gastric carcinoma.Jpn J Surg. 1987 Mar;17(2):83-90. doi: 10.1007/BF02470646. Jpn J Surg. 1987. PMID: 2957537
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous